An FDA advisory panel has recommended that the agency not approve the use of MDMA-assisted therapy as a treatment for PTSD. A U.S. Food and Drug Administration advisory committee voted on Tuesday ...
Also known as molly or ecstasy, MDMA has the potential to treat post-traumatic stress disorder (PTSD). But psychedelic-assisted therapy can only be administered by a trained professional. Without the ...
A decades-long campaign to legalize MDMA as a mainstream medical treatment will reach a climax as soon as Friday, with the Food and Drug Administration poised to decide whether the psychedelic should ...
The agency’s staff analysis suggests that approval of the illegal drug known as Ecstasy for treatment of PTSD is far from certain, with advisers meeting next week to consider the proposed therapy. By ...
As psychedelic-assisted therapy grows in popularity, several substances are being recognized for their potential in treating trauma. Psilocybin, ketamine, and MDMA have emerged as some of the most ...
A panel of experts advising the Food and Drug Administration on the use of the psychedelic MDMA for post-traumatic stress disorder found on Tuesday that the available evidence fails to show that the ...
MDMA (3,4-methylenedioxymethamphetamine), known colloquially as Molly and Ecstasy, is a synthetic drug with effects similar to stimulants like methamphetamine. It was first synthesized in 1912 by ...
Share on Pinterest A key FDA panel voted down approving MDMA-assisted therapy to treat PTSD. pixdeluxe/Getty Images An expert panel of the Food and Drug Administration reviewed two studies on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results